5 Questions For MedImmune's Jallal On Right Culture And Staying Open To Collaboration
This article was originally published in Scrip
Executive Summary
Scrip caught up with Dr. Bahija Jallal, AstraZeneca's executive vice president and head of subsidiary MedImmune, at BIO Europe 2015, in Munich, Germany, to discuss challenges ahead for pharma and biotech firms, how business models are evolving to focus on culture not just size and why collaboration is the gateway to innovation.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.